Overview

A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT)

Status:
Recruiting
Trial end date:
2021-02-28
Target enrollment:
Participant gender:
Summary
An Open-Label, multicenter study in male pediatric patients with cerebral x-linked adrenoleukodystrophy (cald) to assess the effects of MIN-102 treatment on disease progression prior to human stem cell transplant (HSCT)
Phase:
Phase 2
Details
Lead Sponsor:
Minoryx Therapeutics, S.L.